![Strategic Deals in DX Space Remain Low in Number, but High in Impact](https://www.g2intelligence.com/wp-content/uploads/2022/11/Dec22.LIR_.MandA-iStock-1800x1250-1-1080x675.jpg)
Strategic Deals in DX Space Remain Low in Number, but High in Impact
Though only seven transactions were announced or closed in November, two were billion-dollar deals.
Though only seven transactions were announced or closed in November, two were billion-dollar deals.
M&A deals in the diagnostics industry have been lower in number, but higher in impact in recent months.
Continuing recent patterns, M&A deal-making in the diagnostics space was low in volume but high in impact in October.
A roundup of key mergers, acquisitions, and strategic asset purchases in the healthcare industry in September.
It’s beginning to look like Illumina’s roll of the dice is going to come up snake eyes regarding the potential acquisition.